Turin, Italy

Andrea Savarino

USPTO Granted Patents = 3 


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Rome, IT (2014)
  • Turin, IT (2021)

Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Andrea Savarino: Innovator in Cancer and HIV Treatment

Introduction

Andrea Savarino is a prominent inventor based in Turin, Italy. She has made significant contributions to the field of medical research, particularly in the development of treatments for cancer, HIV, and rheumatic diseases. With a total of three patents to her name, her work is recognized for its potential impact on healthcare.

Latest Patents

Andrea Savarino's latest patents include a formulation involving buthionine sulfoximine (BSO) and a metallodrug for the treatment of cancer, HIV, or rheumatic diseases. The disclosed method comprises administering BSO at a dosage of less than or equal to 50 mg/kg, along with a metallodrug at a clinically acceptable dosage. This innovative approach aims to enhance treatment efficacy and improve patient outcomes.

Career Highlights

Throughout her career, Andrea has worked with esteemed institutions such as the Istituto Superiore di Sanità. Her research has focused on developing novel therapeutic strategies that address critical health challenges. Her dedication to advancing medical science has positioned her as a key figure in her field.

Collaborations

Andrea has collaborated with notable colleagues, including Iart Luca Shytaj and Francesco Procopio. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Andrea Savarino's contributions to medical research and her innovative patents highlight her commitment to improving healthcare. Her work continues to inspire future advancements in the treatment of serious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…